Glimbot-MP1 Tablet

Description

Glimepiride 1 mg + Metformin Hydrochloride 500 mg + Pioglitazone 15 mg Tablet is a comprehensive triple-drug anti-diabetic formulation indicated for the management of Type 2 Diabetes Mellitus in patients who require combination therapy for optimal glycemic control.

This synergistic combination works through three complementary mechanisms:

Glimepiride 1 mg stimulates pancreatic insulin secretion to help lower blood glucose levels.
Metformin Hydrochloride 500 mg reduces hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity.
Pioglitazone 15 mg enhances peripheral insulin sensitivity by improving glucose utilization in muscle and adipose tissues.

Manufactured in WHO-GMP certified facilities, this formulation delivers superior quality, safety, and therapeutic efficacy. It is a high-demand product in the diabetology segment, making it an excellent addition to any pharma franchise portfolio.

Key Benefits

✔ Triple-action blood glucose management
✔ Helps improve insulin sensitivity
✔ Supports effective glycemic control in Type 2 Diabetes Mellitus
✔ Helps reduce insulin resistance
✔ Complements diet and exercise for diabetes management
✔ WHO-GMP certified quality manufacturing
✔ High demand anti-diabetic product for pharma franchise

Composition

Glimepiride IP – 1 mg
Metformin Hydrochloride IP – 500 mg
Pioglitazone Hydrochloride equivalent to Pioglitazone – 15 mg

Indications / Uses

Type 2 Diabetes Mellitus
Inadequate glycemic control with dual therapy
Insulin resistance
Long-term diabetes management under physician supervision

Dosage Form

Tablets

(Dosage should be taken strictly as directed by the physician.)

Packaging

Alu-Alu Blister Packaging
Strip Packaging
Premium anti-diabetic packaging
Custom private labeling options

Pharma Franchise Opportunity

We offer Glimepiride + Metformin + Pioglitazone Tablet Pharma Franchise with:

✅ Monopoly franchise rights
✅ WHO-GMP certified manufacturing
✅ High demand diabetic care product
✅ Promotional and marketing support
✅ Competitive pricing with attractive profit margins

This product is an excellent addition to diabetology, endocrinology, and chronic care pharma franchise portfolios, ensuring strong prescription demand and long-term market growth.